DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - Q3 2019 holdings

$2.45 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 95 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 35.1% .

 Value Shares↓ Weighting
HZNP  HORIZON THERAPEUTICS PUB LTD$175,978,000
+13.2%
6,462,6340.0%7.18%
+28.5%
 HORIZON PHARMA INVT LTDnote 2.500% 3/1$158,106,000
+5.0%
136,032,0000.0%6.45%
+19.2%
MYL BuyMYLAN N V$151,397,000
+6.5%
7,654,065
+2.5%
6.17%
+20.9%
 NEVRO CORPnote 1.750% 6/0$131,363,000
+8.9%
115,776,0000.0%5.36%
+23.6%
ORTX  ORCHARD THERAPEUTICS PLCads$106,012,000
-15.1%
8,923,6000.0%4.32%
-3.6%
FIXX  HOMOLOGY MEDICINES INC$104,263,000
-7.5%
5,760,3680.0%4.25%
+5.0%
AERI BuyAERIE PHARMACEUTICALS INC$87,813,000
-2.0%
4,568,824
+50.6%
3.58%
+11.2%
RYTM BuyRHYTHM PHARMACEUTICALS INC$55,903,000
+307.2%
2,589,291
+315.0%
2.28%
+362.3%
BKD  BROOKDALE SR LIVING INC$54,631,000
+5.1%
7,207,2390.0%2.23%
+19.3%
XENT  INTERSECT ENT INC$52,884,000
-25.3%
3,109,0040.0%2.16%
-15.2%
XLRN  ACCELERON PHARMA INC$51,567,000
-3.8%
1,305,1740.0%2.10%
+9.1%
MYOK SellMYOKARDIA INC$51,182,000
+2.4%
981,430
-1.6%
2.09%
+16.2%
 INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0$49,530,000
-3.6%
57,791,0000.0%2.02%
+9.4%
IMMU SellIMMUNOMEDICS INC$42,618,000
-38.4%
3,214,000
-35.5%
1.74%
-30.0%
BuyCLOVIS ONCOLOGY INCnote 2.500% 9/1$42,262,000
+165.8%
49,064,000
+172.6%
1.72%
+201.8%
RARX BuyRA PHARMACEUTICALS INC$40,868,000
-20.7%
1,728,019
+0.9%
1.67%
-9.9%
MIRM NewMIRUM PHARMACEUTICALS INC$34,696,0003,448,912
+100.0%
1.42%
SellKEMPHARM INCnote 5.500% 2/0$32,179,000
+1.7%
62,423,000
-4.6%
1.31%
+15.5%
ARGX  ARGENX SEsponsored adr$32,023,000
-19.5%
281,0000.0%1.31%
-8.6%
SILK BuySILK ROAD MEDICAL INC$31,862,000
+31.8%
979,480
+96.3%
1.30%
+49.5%
VCEL BuyVERICEL CORP$31,506,000
-19.4%
2,081,000
+0.6%
1.28%
-8.5%
CHRS SellCOHERUS BIOSCIENCES INC$31,207,000
-15.8%
1,540,305
-8.2%
1.27%
-4.5%
CNC BuyCENTENE CORP DEL$31,165,000
+96.1%
720,400
+137.8%
1.27%
+122.6%
FATE BuyFATE THERAPEUTICS INC$30,328,000
-12.3%
1,952,897
+14.7%
1.24%
-0.5%
ALEC BuyALECTOR INC$29,948,000
-9.8%
2,076,812
+18.9%
1.22%
+2.4%
SRPT BuySAREPTA THERAPEUTICS INC$28,772,000
-38.7%
382,000
+23.6%
1.17%
-30.5%
SEM SellSELECT MED HLDGS CORP$28,403,000
-12.4%
1,714,099
-16.1%
1.16%
-0.6%
BPMC SellBLUEPRINT MEDICINES CORP$27,713,000
-24.9%
377,200
-3.6%
1.13%
-14.8%
DBVT  DBV TECHNOLOGIES S Asponsored adr$27,531,000
+4.6%
3,201,2220.0%1.12%
+18.7%
TNDM BuyTANDEM DIABETES CARE INC$26,797,000
+172.4%
454,334
+197.9%
1.09%
+209.6%
SIEN SellSIENTRA INC$26,811,000
-6.4%
4,137,470
-11.1%
1.09%
+6.2%
EDIT  EDITAS MEDICINE INC$26,352,000
-8.1%
1,158,8410.0%1.07%
+4.3%
 PTC THERAPEUTICS INCnote 3.000% 8/1$25,902,000
-6.0%
24,877,0000.0%1.06%
+6.7%
DFBHU  DFB HEALTHCARE ACQUISTION COunit 01/30/2023$25,800,000
-0.5%
2,500,0000.0%1.05%
+13.0%
AXGN BuyAXOGEN INC$22,992,000
+30.3%
1,842,330
+106.7%
0.94%
+47.8%
SWTX NewSPRINGWORKS THERAPEUTICS INC$22,783,0001,050,888
+100.0%
0.93%
XERS SellXERIS PHARMACEUTICALS INC$22,694,000
-16.6%
2,308,666
-3.0%
0.92%
-5.4%
MOH BuyMOLINA HEALTHCARE INC$21,621,000
+0.7%
197,056
+31.4%
0.88%
+14.3%
RCKT BuyROCKET PHARMACEUTICALS INC$20,666,000
+21.2%
1,773,938
+56.0%
0.84%
+37.5%
DCPH SellDECIPHERA PHARMACEUTICALS IN$20,185,000
+47.3%
594,725
-2.1%
0.82%
+67.3%
ADUS  ADDUS HOMECARE CORP$20,051,000
+5.8%
252,9150.0%0.82%
+20.0%
ARVN  ARVINAS INC$19,853,000
-2.0%
921,2340.0%0.81%
+11.1%
MRTX SellMIRATI THERAPEUTICS INC$18,153,000
-33.4%
233,000
-11.9%
0.74%
-24.4%
HUM  HUMANA INC$17,130,000
-3.6%
67,0000.0%0.70%
+9.4%
WVE BuyWAVE LIFE SCIENCES LTD$16,583,000
-5.0%
807,727
+20.7%
0.68%
+7.8%
ARDX SellARDELYX INC$15,982,000
+71.6%
3,400,410
-1.8%
0.65%
+95.2%
 WRIGHT MED GROUP N Vnote 2.250%11/1$15,941,000
-21.0%
13,625,0000.0%0.65%
-10.3%
PTCT  PTC THERAPEUTICS INC$15,929,000
-24.8%
471,0000.0%0.65%
-14.7%
RETA  REATA PHARMACEUTICALS INCcl a$15,817,000
-14.9%
197,0000.0%0.64%
-3.4%
GLPG  GALAPAGOS NVspon adr$15,420,000
+18.4%
101,0100.0%0.63%
+34.4%
ANAB SellANAPTYSBIO INC$14,886,000
-51.2%
425,443
-21.3%
0.61%
-44.6%
DPLO SellDIPLOMAT PHARMACY INC$14,682,000
-65.7%
2,996,328
-57.4%
0.60%
-61.1%
TPTX BuyTURNING POINT THERAPEUTICS I$14,572,000
+24.5%
387,545
+34.8%
0.59%
+41.4%
BOLD  AUDENTES THERAPEUTICS INC$13,874,000
-25.8%
493,9010.0%0.57%
-15.8%
SYRS  SYROS PHARMACEUTICALS INC$13,172,000
+12.1%
1,268,9460.0%0.54%
+27.3%
GBT BuyGLOBAL BLOOD THERAPEUTICS IN$13,008,000
+5.2%
268,100
+14.1%
0.53%
+19.4%
AVDL  AVADEL PHARMACEUTICALS PLCsponsored adr$11,325,000
+44.0%
2,722,2410.0%0.46%
+63.3%
KNSA SellKINIKSA PHARMACEUTICALS LTD$10,842,000
-38.9%
1,274,086
-2.8%
0.44%
-30.6%
KALV SellKALVISTA PHARMACEUTICALS INC$10,332,000
-61.7%
890,668
-26.9%
0.42%
-56.6%
MNKKQ BuyMALLINCKRODT PUB LTD CO$10,101,000
-73.7%
4,191,327
+0.3%
0.41%
-70.1%
INGN NewINOGEN INC$9,182,000191,660
+100.0%
0.37%
GH NewGUARDANT HEALTH INC$8,043,000126,000
+100.0%
0.33%
BCRX SellBIOCRYST PHARMACEUTICALS$7,949,000
-66.7%
2,774,643
-55.9%
0.32%
-62.2%
EHTH SellEHEALTH INC$7,347,000
-72.6%
110,000
-64.6%
0.30%
-68.8%
ATRC NewATRICURE INC$7,302,000292,777
+100.0%
0.30%
XFOR SellX4 PHARMACEUTICALS INC$7,165,000
-15.5%
563,741
-0.2%
0.29%
-3.9%
AIMT NewAIMMUNE THERAPEUTICS INC$7,109,000339,480
+100.0%
0.29%
AVRO NewAVROBIO INC$7,060,000500,000
+100.0%
0.29%
BBIO  BRIDGEBIO PHARMA INC$6,226,000
-20.4%
290,0000.0%0.25%
-9.6%
 TELIGENT INC NEWnote 4.750% 5/0$5,550,000
+9.6%
9,567,0000.0%0.23%
+24.2%
MDCO  MEDICINES COput$5,000,000
+37.1%
100,0000.0%0.20%
+55.7%
PRVB NewPROVENTION BIO INC$4,948,000725,000
+100.0%
0.20%
ABMD NewABIOMED INC$4,910,00027,600
+100.0%
0.20%
FTSV NewFORTY SEVEN INC$4,815,000750,000
+100.0%
0.20%
IGMS NewIGM BIOSCIENCES INC$4,438,000250,000
+100.0%
0.18%
ALIM BuyALIMERA SCIENCES INC$4,000,000
-25.7%
7,062,607
+16.7%
0.16%
-16.0%
AGLE  AEGLEA BIOTHERAPEUTICS INC$3,845,000
+12.3%
500,0460.0%0.16%
+27.6%
IDYA SellIDEAYA BIOSCIENCES INC$3,807,000
-10.1%
422,974
-0.5%
0.16%
+2.0%
HARP SellHARPOON THERAPEUTICS INC$3,613,000
-2.5%
264,497
-7.2%
0.15%
+10.5%
MOR SellMORPHOSYS AGsponsored ads$3,426,000
-76.3%
124,701
-79.2%
0.14%
-73.1%
BDSI  BIODELIVERY SCIENCES INTL IN$3,436,000
-9.5%
816,0960.0%0.14%
+2.9%
STIM BuyNEURONETICS INC$2,821,000
+41.8%
339,512
+113.5%
0.12%
+62.0%
ITMR  ITAMAR MED LTDsponsored ads$2,749,000
-20.4%
314,1360.0%0.11%
-9.7%
ATEC NewALPHATEC HOLDINGS INC$2,693,000536,517
+100.0%
0.11%
SYBX  SYNLOGIC INC$2,537,000
-74.8%
1,107,6430.0%0.10%
-71.5%
AGRX NewAGILE THERAPEUTICS INC$1,886,0001,591,652
+100.0%
0.08%
CSTL NewCASTLE BIOSCIENCES INC$1,673,00092,477
+100.0%
0.07%
ALPN SellALPINE IMMUNE SCIENCES INC$1,611,000
-8.0%
406,926
-2.2%
0.07%
+4.8%
VRAY NewVIEWRAY INC$1,098,000378,623
+100.0%
0.04%
EYEN SellEYENOVIA INC$729,000
-43.5%
197,069
-34.3%
0.03%
-34.8%
NEOS  NEOS THERAPEUTICS INC$475,000
+14.7%
320,9930.0%0.02%
+26.7%
KMPH NewKEMPHARM INC$477,000692,104
+100.0%
0.02%
MNLO SellMENLO THERAPEUTICS INC$446,000
-62.5%
99,622
-49.8%
0.02%
-58.1%
PRTO  PROTEON THERAPEUTICS INC$318,000
-37.6%
1,224,8990.0%0.01%
-27.8%
CNST SellCONSTELLATION PHARMCETICLS I$152,000
-93.3%
23,600
-87.1%
0.01%
-92.6%
KIDS ExitORTHOPEDIATRICS CORP$0-32,000
-100.0%
-0.04%
PFNX ExitPFENEX INC$0-394,255
-100.0%
-0.10%
ADPT ExitADAPTIVE BIOTECHNOLOGIES COR$0-70,000
-100.0%
-0.12%
SRNE ExitSORRENTO THERAPEUTICS INC$0-2,091,461
-100.0%
-0.20%
ACRS ExitACLARIS THERAPEUTICS INC$0-3,983,025
-100.0%
-0.31%
CHWY ExitCHEWY INCcl a$0-261,337
-100.0%
-0.33%
INSP ExitINSPIRE MED SYS INC$0-151,106
-100.0%
-0.33%
PHAS ExitPHASEBIO PHARMACEUTICALS INC$0-851,005
-100.0%
-0.40%
ATNX ExitATHENEX INC$0-621,859
-100.0%
-0.44%
ANTM ExitANTHEM INC$0-53,000
-100.0%
-0.54%
SWAV ExitSHOCKWAVE MED INC$0-312,146
-100.0%
-0.64%
NVTA ExitINVITAE CORP$0-995,312
-100.0%
-0.84%
NVRO ExitNEVRO CORP$0-386,000
-100.0%
-0.90%
STAA ExitSTAAR SURGICAL CO$0-876,512
-100.0%
-0.92%
ExitEXACT SCIENCES CORPnote 1.000% 1/1$0-15,000,000
-100.0%
-0.93%
NTRA ExitNATERA INC$0-1,002,834
-100.0%
-0.99%
ExitDEXCOM INCnote 0.750% 5/1$0-20,000,000
-100.0%
-1.15%
ExitINSULET CORPnote 1.375%11/1$0-36,650,000
-100.0%
-1.87%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AERIE PHARMACEUTICALS INC36Q3 20223.6%
CENTENE CORP DEL30Q3 20233.0%
BIOCRYST PHARMACEUTICALS INC29Q3 20232.2%
MOLINA HEALTHCARE INC26Q3 20221.7%
EHEALTH INC25Q3 20202.0%
INTERCEPT PHARMACEUTICALS IN24Q1 20232.2%
MYLAN NV23Q3 20206.2%
PORTOLA PHARMACEUTICALS INC23Q1 20196.0%
BROOKDALE SR LIVING INC23Q3 20232.2%
ALIMERA SCIENCES INC23Q3 20190.8%

View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.

Latest significant ownerships (13-D/G)
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) Q3 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
DA32 Life Science Tech Acquisition Corp.August 01, 20235,145,00091.1%
CareMax, Inc.March 13, 202318,691,42316.4%
CareMax, Inc.June 02, 202218,691,42320.7%

View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.

Latest filings
TypeFiled
32024-03-19
42024-03-19
42024-03-12
32024-03-08
42024-02-16
13F-HR2024-02-14
42024-02-08
32024-02-01
42023-11-21
13F-HR2023-11-14

View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (2452801000.0 != 2452802000.0)

Export DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s holdings